Annual Health Screening for Women 40+ in Stockholm — A 2026 Guide

For women in their 40s, the public Swedish screening system covers a few key items: mammography from 40, cervical cytology every 3-7 years, and a couple of opportunistic checks via Vårdcentral. That's a perfectly reasonable population-level screening minimum. It's not a comprehensive annual evaluation for a woman who wants to know what's actually happening across her cardiovascular, metabolic, hormonal, bone, and cognitive systems heading into the perimenopausal decade.

This guide covers what comprehensive annual screening for women 40+ should include in Stockholm — what the public system covers, what it doesn't, and what's worth adding privately.

What the public system covers (and when)

That's the screening minimum. Vårdcentral may add basic blood work if you have specific symptoms — but it's reactive, not preventive, and not comprehensive.

What's typically missed at the 40+ inflection point

This is the decade where several things start to shift:

• Perimenopause begins (typically 40-50). Estradiol becomes erratic; progesterone declines; FSH starts to climb. Symptoms can begin 7-10 years before final menstrual period.
• Cardiovascular risk accelerates — particularly after estrogen begins declining. Lipid profile changes, often unfavourably.
• Bone mineral density starts to decline — measurable years before clinical osteoporosis
• Thyroid disorders become more common — autoimmune thyroiditis affects 5-15% of women in this age range
• Insulin sensitivity declines — even at stable weight, glucose handling can worsen
• Iron status can shift dramatically with cycle changes during perimenopause
• Cognitive symptoms (brain fog, word-finding) often start in late 40s

None of these are addressed by mammography + cervical cytology.

What comprehensive annual screening should include for women 40+

Cardiovascular

• Full lipid panel (total, LDL, HDL, triglycerides, apoB — the most predictive single lipid marker)
• Lp(a) — measured once in lifetime
• hs-CRP (inflammation)
• Resting ECG
• Blood pressure (correctly measured, both arms)
• Coronary artery calcium score (CAC) — optional, very high prognostic value once over 45

Metabolic

• HbA1c
• Fasting glucose + fasting insulin (HOMA-IR)
• Liver enzymes (ALT, AST, GGT)
• TSH + free T4 + free T3 + anti-TPO (full thyroid panel)

Hormonal (perimenopause-specific)

• Estradiol (cycle-timed if still cycling, or any time if amenorrhoeic)
• Progesterone (cycle-timed)
• FSH + LH
• DHEA-S
• Total + free testosterone
• SHBG

Cancer screening

• Mammography (every 1-2 years)
• HPV / cervical screening (per Swedish schedule)
• Skin examination by dermatologist annually (sun damage decade)
• Stool occult blood / FIT test from 50
• Optional: whole-body MRI (cancer + structural baseline)

Bone

• DEXA bone density scan — baseline at 40-45, then per indication
• 25-OH vitamin D
• Calcium, parathyroid hormone (if vit D low or bone density abnormal)

Nutritional / blood

• Full blood count
• Iron, ferritin, transferrin saturation (heavy menstrual bleeding often goes underrecognised)
• Vitamin B12 + holotranscobalamin
• Folate
• Magnesium (RBC)
• Vitamin D

Pelvic / gynecology

• Annual gynaecology consultation
• Pelvic ultrasound (assess endometrial thickness, fibroids, ovarian morphology)

Other

• Comprehensive medical history review
• Mental health screening (perimenopause depression is real, often missed)
• Sleep assessment (sleep architecture shifts during perimenopause)

The "perimenopause hidden decade"

This is the term clinicians increasingly use for women aged 40-50 whose symptoms — fatigue, sleep disruption, anxiety, weight changes, joint pain, brain fog, libido changes — are often dismissed or misattributed.

A proper hormonal panel cycle-timed against clinical assessment can identify:

• Estrogen dominance (relative or absolute)
• Progesterone deficiency
• Thyroid dysregulation (often missed because TSH alone is normal while reverse T3 is elevated)
• Adrenal stress pattern (cortisol curve flattened)
• Androgen decline (testosterone, DHEA-S)

These findings inform whether menopausal hormone therapy (MHT), thyroid intervention, or other targeted intervention is appropriate. The evidence base for MHT in symptomatic perimenopausal women is now substantially stronger than the WHI-era hesitancy suggested.

What this costs in Stockholm

For women 40-50 specifically, Health 360 is often the natural fit — it's the first tier that includes whole-body MRI (structural baseline before any age-related risk accumulates) plus the comprehensive biomarker depth that perimenopause evaluation needs, plus the 12-month physician program that lets findings actually translate to action.

How to think about screening cadence

• Comprehensive baseline: Once, at 40-45. Establishes structural and biomarker reference for future comparisons.
• Annual lighter check: Cardiovascular + metabolic + hormonal biomarkers each year
• MRI re-scan: Every 3-5 years unless clinical change indicates sooner
• DEXA re-scan: Every 2-5 years depending on baseline
• Mammography: Per Swedish public schedule (every 18-24 months) supplemented if dense-tissue or family history indicates
• Gynae: Annual

FAQs

Is annual screening worth it if I feel fine?

The point of preventive screening is precisely to catch what hasn't presented yet. The 40-50 decade is when several silent shifts begin — lipid trajectory, bone density decline, hormonal transition, insulin sensitivity. Knowing the trajectory matters more than the snapshot.

I'm in perimenopause but my doctor said hormones are normal — is that reliable?

Perimenopausal hormones fluctuate so much that single timepoint measurements are often uninformative. Cycle-timed measurements, repeated over 2-3 cycles, give more usable data. Symptoms often outweigh biochemistry in MHT decision-making.

Should I add coronary artery calcium scoring (CAC)?

Often yes from 45-50 if there's any cardiovascular family history, smoking history, or unfavourable lipids. CAC is the single highest-predictive cardiac risk tool available outside catheterisation, and zero-CAC is genuinely reassuring.

Is whole-body MRI useful at 40 if I feel fine?

Useful primarily as a one-time structural baseline. The Swedish socialstyrelsen position is that whole-body MRI is not population-screening-validated — meaning we shouldn't expect it to lower all-cause mortality at the population level. But for individual baseline establishment and finding incidental treatable conditions, the evidence is reasonable.

Does Försäkringskassan or Cigna cover annual screening?

Försäkringskassan doesn't fund elective screening. Cigna Global, Allianz Care, AXA Global Healthcare typically cover preventive screening at Premium tier or above — we direct-bill all three.

What about screening if I have a family history of breast or ovarian cancer?

You should be on the regional high-risk surveillance program if family history meets criteria (BRCA1/2, multiple first-degree relatives). Genetic counselling is appropriate. Comprehensive screening can supplement but shouldn't replace surveillance pathways.

Should men do similar screening?

Yes — see our screening pages for executive screening programs (men typically benefit from the same comprehensive cardiovascular + metabolic + hormonal evaluation, plus prostate-specific screening from 45-50).

Book annual screening at The Health Clinic Stockholm →

Written by the clinical team at The Health Clinic Stockholm. Kungstensgatan 2, Östermalm. Comprehensive annual screening, in-house gynaecology + endocrinology + cardiology. English-speaking. Direct billing for Cigna Global, Allianz Care, AXA Global Healthcare.